Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Other Liabilities
Modalis Therapeutics Corp
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Other Liabilities
¥34.9m
|
CAGR 3-Years
3 168%
|
CAGR 5-Years
710%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Other Liabilities
¥14.2B
|
CAGR 3-Years
31%
|
CAGR 5-Years
38%
|
CAGR 10-Years
56%
|
|
PeptiDream Inc
TSE:4587
|
Other Liabilities
¥476.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Other Liabilities
¥1.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Other Liabilities
¥34.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
S
|
StemRIM Inc
TSE:4599
|
Other Liabilities
¥108.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Other Liabilities?
Other Liabilities
34.9m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Other Liabilities amounts to 34.9m JPY.
What is Modalis Therapeutics Corp's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
710%
Over the last year, the Other Liabilities growth was -25%. The average annual Other Liabilities growth rates for Modalis Therapeutics Corp have been 3 168% over the past three years , 710% over the past five years .